NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary

Q: What sector and industry does NeuBase Therapeutics (NBSE) operate in?

NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.

Open	$0.411
Close	$0.430
Volume / Avg.	88.865K / 230.205K
Day Range	0.410 - 0.433
52 Wk Range	0.390 - 5.400
Market Cap	$1.542M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	4.26%
Days to Cover	1

Recent News

Why Neubase Therapeutics (NBSE) Shares Are Nosediving

Henry Khederian

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.

Avi Kapoor

Nasdaq Gains Over 50 Points; US Durable Goods Orders Rise In February

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Tuesday. The Dow traded up 0.08% to 39,346.40 while the NASDAQ rose 0.39% to 16,448.92. The S&P 500 also rose, gaining, 0.23% to 5,230.19.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

1.8

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

About NeuBase Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the dev...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NeuBase Therapeutics (NBSE) stock?

You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.

View our list of the best stock brokerages.

Who are NeuBase Therapeutics's (NBSE) competitors?

Other companies in NeuBase Therapeutics’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Bone Biologics (NASDAQ:BBLG), Quoin Pharmaceuticals (NASDAQ:QNRX), Qualigen Therapeutics (NASDAQ:QLGN) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).

What is the target price for NeuBase Therapeutics (NBSE) stock?

The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for NeuBase Therapeutics (NBSE)?

The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.411 last updated Today at April 19, 2024 at 8:53 AM EDT.

Does NeuBase Therapeutics (NBSE) pay a dividend?

There are no upcoming dividends for NeuBase Therapeutics.

When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?

NeuBase Therapeutics’s Q2 earnings are confirmed for Thursday, May 9, 2024.

Is NeuBase Therapeutics (NBSE) going to split?

There is no upcoming split for NeuBase Therapeutics.

What sector and industry does NeuBase Therapeutics (NBSE) operate in?

NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-